XGN

3.6105.00%
FS

Frank Stokes

CFO & Treasurer

Mr. Frank Stokes has been Chief Financial Officer of Castle Biosciences Incorporated since December 4, 2017 and serves as its Treasurer. Mr. Stokes has been Independent Director at Exagen Inc. since June 17, 2021. Mr. Stokes has extensive experience leading capital formation for high-growth companies and was Chief Financial Officer of Hammock Pharmaceuticals from January 2017 to December 2017 and previously as a Managing Director of Leerink Swann from May 2011 to December 2016. He joined Castle Biosciences on December 4, 2017. He has financial accumen, expertise in capital markets, success with mergers and acquisitions and a deep knowledge of the diagnostics industry all of which helps team to continue the mission to improve patient care decisions and deliver shareholder value. Mr. Stokes joins Castle Biosciences with experience in finance. As Chief Financial Officer of Hammock Pharmaceuticals, he assisted in the initial capitalization of the company, as well as the acquisition of Hammock foundational drug delivery technology. Prior to Hammock, Mr. Stokes served as a Managing Director at Robert W. Baird and Wachovia Securities (now Wells Fargo Securities). Mr. Stokes received a B.S. in business administration followed by MBA and J.D. degrees from the University of North Carolina at Chapel Hill.

Positions